Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma

BACKGROUND: Granulocyte macrophage colony-stimulating factor (GM-CSF) is currently widely used as an adjuvant in cancer immunotherapy. However, recent studies have shown that GM-CSF can impair anti-tumor immune responses. Thus the role of GM-CSF in clear-cell renal cell carcinoma (ccRCC) remains unr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Yuan, Xu, Le, Zhou, Lin, Fu, Qiang, Liu, Zheng, Yang, Yuanfeng, Lin, Zongming, Xu, Jiejie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029719/
https://www.ncbi.nlm.nih.gov/pubmed/27016418
http://dx.doi.org/10.18632/oncotarget.8235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5029719/
https://www.ncbi.nlm.nih.gov/pubmed/27016418
http://dx.doi.org/10.18632/oncotarget.8235

Ejemplares similares